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Objective: Recent literature has questioned the efficacy of routine detailed preopera-
tive cardiac ischemia testing and preoperative cardiac intervention before noncardiac
surgical procedures.
Methods: We performed a retrospective review of patients undergoing thoracotomy
(n 5 294) between January of 1999 and January of 2005.
Results: The median age was 62 years. Detailed preoperative cardiac testing was per-
formed on 184 patients (63%) and went beyond a thorough history, physical exami-
nation, and electrocardiogram to include at least one of the following: dobutamine
stress echo (n5 116), nuclear stress test (n5 66), treadmill test (n5 8), and coronary
angiogram (n5 40). Evidence for coronary disease was detected in 43% of tests (99/
230) performed. Revascularization was performed in 10% of all patients (4/40) who
underwent coronary angiography. Postoperative myocardial infarction occurred in 7
patients (2.4%) with 4 myocardial infarction-related mortalities. No significant differ-
ence was found in the incidence of myocardial infarction in patients with (n5 184) or
without (n 5 110) detailed preoperative cardiac testing (3.3% vs 0.9%,
P5 .29). Of the 4 patients (1.4%) who underwent revascularization to treat coronary
lesions identified during prethoracotomy workup, 2 had a myocardial infarction, 1 of
which was caused by thrombosis of a coronary stent. In the subset of patients who un-
derwent lobectomy (n5 149), detailed cardiac testing was performed on 107 patients
(72%). The incidence of myocardial infarction was similar in tested and untested
patients (2.8% vs 2.4% respectively, P 5 1.0).
Conclusion: Selective use of detailed preoperative cardiac testing refines risk stratifi-
cation and identifies patients for corrective cardiac interventions; however, it did not
prove fully protective against myocardial infarction after thoracotomy in our study.
P
atients scheduled for general thoracic operations often undergo a preoperative
cardiac evaluation in an effort to both risk stratify and minimize the perioper-
ative incidence of cardiac events. The presumption is that rigorous analysis
would identify patients at risk and expose potentially correctable cardiac lesions.
Therapeutic interventions addressing the lesions can then be performed preopera-
tively, thus reducing cardiovascular complications at the time of surgery.
There is a growing body of evidence that in this era of optimal medical treatment,
noninvasive cardiac testing should be reserved for patients at a qualifying level of
risk.1,2 Moreover, preoperative revascularization in patients being evaluated before
noncardiac surgery is controversial. The theme of the recent literature is that preoper-
ative cardiac intervention is rarely necessary simply to decrease the risk of surgery un-
less such intervention is indicated irrespective of the preoperative context.2,3 In fact,
preoperative coronary revascularization does not seem to reduce perioperative risk in
patients with significant but stable coronary artery disease (CAD).4,5
There are conflicting issues that drive preoperative cardiac evaluation today. The
current medico-legal environment is intolerant of adverse outcomes, whereas com-
monsense medical practice and economic pressures in health care would minimize
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TSAbbreviations and Acronyms
CABG 5 coronary artery bypass grafting
CAD 5 coronary artery disease
DSE 5 dobutamine stress echocardiogram
ECG 5 electrocardiogram
EST 5 exercise treadmill stress test
LAD 5 left anterior descending
MI 5 myocardial infarction
PTCA 5 percutaneous transluminal coronary angioplasty
Pthal 5 Persantine thallium stress test
unnecessary testing. The American College of Cardiology/
American Heart Association guidelines1,2 consider thoracic
procedures as medium risk. There is little information in
the literature regarding the actual risks in the population
undergoing thoracic surgery, the impact of preoperative
noninvasive cardiac testing, and the benefits of corrective
preoperative coronary revascularization.
Our institution serves as a tertiary referral center, and our
patients tend to have multiple comorbidities. Until recently,
the bias has been to perform detailed preoperative myocardial
ischemia testing on the majority of patients undergoing
elective thoracotomy. Our objective was to assess the
incidence of myocardial infarction (MI) in patients undergo-
ing thoracotomy, including the subset of patients undergoing
lobectomy, and to evaluate the impact of detailed preoperative
cardiac testing.We also sought to determine whether revascu-
larization performed because of CAD identified during pre-
thoracotomyworkupwas protective against postoperativeMI.
Materials and Methods
With institutional review board approval, a retrospective review was
performed of all patients undergoing open thoracotomy at the Mi-
chael E. DeBakey Veterans Affairs Medical Center between January
of 1999 and January of 2005. Waiver of individual consent was
granted because the study did not involve any form of patient con-
tact. Thoracotomy surgeries subject to the study included lung biop-
sies or resections, decortications, benign and malignant mediastinal
lesions, and thoracic spine exposures. The access incision involved
a posterolateral thoracotomy with division of the latissimus dorsi
muscle and rib spreading with or without rib division or resection.
All esophagectomies, video-assisted thoracoscopic procedures,
and surgeries involving minimal access incisions that did not in-
volve rib spreading were excluded. Data were extracted from the pa-
tient charts and the Veterans Affairs computerized patient record
system, including patient demographics, risk factors, preoperative
cardiac symptoms, cardiac workup, interventions, and subsequent
cardiac complications.
All patients underwent a rigorous clinical evaluation that in-
cluded a full history and physical examination. Preoperative electro-
cardiograms (ECGs) were obtained routinely for all patients.
Transthoracic echocardiography was occasionally performed to
evaluate the cardiac valves if a murmur was detected or to measure
the ejection fraction. Patients were classified as having a positiveThe Journal of Thorhistory of CAD when there were clear documentations of such in
the medical records, symptoms consistent with CAD, or an abnor-
mal ECG.
For the purposes of this study, detailed cardiac testing was de-
fined as 1 or a combination of the following procedures: dobutamine
stress echocardiogram (DSE), Persantine thallium stress test (Pthal)
or exercise treadmill stress test (EST), or coronary angiogram. At
our institution the bias was to perform noninvasive testing (DSE,
Pthal, and EST) on the majority of patients undergoing a thoracot-
omy. The decision for testing was not always guided by the magni-
tude of the cardiac risk level determined by the clinical evaluation
(history, physical, and ECG). More than 1 test was performed in
patients because of inconclusive test results or the presence of an
indication for a definitive diagnostic cardiac catheterization. The
most common indication for coronary angiography was a large
area of the heart at risk with more than moderate ischemia on
noninvasive testing.
Cardiac interventions were defined as any invasive therapeutic
procedure, including percutaneous transluminal coronary angio-
plasty (PTCA), percutaneous stenting, and coronary artery bypass
grafting (CABG). The criteria for postoperative MI were elevation
in cardiac enzymes associated with ischemic manifestations, includ-
ing chest pain, congestive heart failure, or hemodynamic changes, or
elevation in enzymes associated with electrocardiographic changes
occurring within 30 days of surgery. Isolated transient postoperative
atrial fibrillation or other self-limiting arrhythmia were not tracked
for the purposes of this study unless they were associated with or
led to MI.
Perioperative beta-blockers were routinely administered to all
patients with known cardiovascular disease. Postoperative tachycar-
dia and hypertension were treated aggressively with beta-blockers as
the first-line medications. In the absence of bleeding concerns, aspi-
rin was often added postoperatively, and a deep venous thrombosis
prophylaxis regimen of either subcutaneous heparin or sequential
compressive devices was instituted. Epidural analgesia is sparingly
used in the practice of our anesthesia department and was not used in
this study cohort.
Unless otherwise specified, we presented the quantitative data as
mean 6 standard deviation and categoric data as percentages. For
parametric variables, we used the Student t test to compare the dif-
ferences between the patients who underwent detailed preoperative
cardiac testing and the patients who did not. For categoric variables,
Fisher’s 2-tailed exact test was used to compare between the tested
and nontested groups. Statistical analyses were conducted using the
Statistical Package for the Social Sciences version 13.0 (SPSS Inc,
Chicago, Ill).
Results
Patient Characteristics
A total of 294 patients underwent a full thoracotomy. The
median age was 62 years (range 29–86 years). Only 7
patients were female, which is not unexpected in a Veterans
Affairs population. For the subset of patients who underwent
lobectomy (n 5 149), the median age was 65 years (range
40–86 years) and only 3 were female. Preoperative medical
comorbidities and risk factors are summarized in Table 1.
Thirty percent of patients had a history of CAD. All revascu-
larization procedures, including CABG, PTCA, and coronaryacic and Cardiovascular Surgery c Volume 135, Number 3 649
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therefore did not include the interventions ordered during the
preoperative workup.
Diagnosis and Procedures
The underlying pathologic condition was primary cancer
(n 5 190), metastatic cancer (n 5 10), and benign diseases
or infection (n 5 94). The surgeries performed were diverse
in type, extent, and indications. Lung resections (n 5 236,
80%) accounted for the majority of the operations and in-
cluded pneumonectomy (n5 24), lobectomy (n5 149), bilo-
bectomy (n 5 8), wedge resection (n 5 54), and sleeve
resection (n5 1). Exposure for thoracic spine access and pleu-
ral procedures, including pleural evacuation/decortications
for hemothorax and empyema,were the secondmost common
surgical category (n 5 53). Mediastinal and diaphragmatic
surgery (n 5 5) accounted for the remaining procedures.
TABLE 1. Patients' risk profile
Comorbidities
Thoracotomy
n 5 294 (%)
Lobectomy subset
n 5 149 (%)
Smoker 256 (87) 135 (90)
Emphysema 121 (41) 62 (41)
Diabetes 65 (22) 28 (19)
Hypertension 161 (55) 87 (58)
Renal insufficiency 12 (4) 5 (3.3)
Stroke 8 (3) 6 (4)
Peripheral vascular disease 6 (2) 3 (2)
Coronary artery disease 88 (30) 45 (30)
Congestive heart failure 16 (5) 7 (5)
Myocardial infarction 34 (12) 20 (13)
Previous CABG 20 (7) 11 (7)
Previous PTCA/stent 6 (2) 1 (1)
CABG, Coronary artery bypass grafting; PTCA, percutaneous transluminal
coronary angioplasty.650 The Journal of Thoracic and Cardiovascular Surgery c MarCardiac Workup
A comprehensive history and physical examination with an
ECG were performed in all patients undergoing a thoracot-
omy (n 5 294). Detailed testing was performed on 184 pa-
tients (63%) (Figure 1). Detailed cardiac testing (n 5 230
tests) included 1 or a combination of DSE (n 5 116), Pthal
(n 5 66), EST (n 5 8), and coronary angiogram (n 5 40).
Abnormal findings were reported in 99 (43%) of those tests.
Figure 2 summarizes the choice and frequency of use of
the various cardiac testing modalities for 3 distinct categories
of patients undergoing thoracotomy: 1) patients with no his-
tory of CAD, 2) patients with a history of CAD, and 3) pa-
tients with symptomatic CAD (subset of patients with
history of CAD). The rates of positive findings of the differ-
ent testing modalities for each of the 3 patient categories are
also demonstrated. In the subset of patients undergoing lo-
bectomy, the corresponding data are displayed in Figure 3.
Cardiac Ischemia and Intervention
Evidence of ischemia was detected in 75 patients (26%) un-
dergoing a thoracotomy by detailed noninvasive testing
(DSE, Pthal, or EST). Coronary angiography was performed
in 29 of those patients: 11 with a significant coronary lesion, 9
with anonhemodynamically significant lesion, and9with a to-
tally normal coronary anatomy. Eleven additional angiograms
were performed because of a concerning history and ECG
findings, and 4 of those angiograms were significantly abnor-
mal. Revascularization was performed in 10% of all patients
(4/40) who underwent coronary angiography. Themedian de-
lay between the intervention and the surgery was 39.5 days.
Evidence of ischemia was detected in 45 patients (30%)
who underwent a lobectomy by DSE, Pthal, or EST. Coro-
nary angiography was performed in 21 of those patients: 9
with a significant coronary lesion, 9 with a nonhemodynami-
cally significant lesion, and 3 with a totally normal coronaryFigure 1. Schematic illustration of the number of
patients (n 5 184) undergoing various cardiac
testing procedures. EST, Exercise treadmill stress
test; DSE, dobutamine stress echocardiogram;
Pthal, Persantine thallium stress test; Cath, car-
diac catheterization.ch 2008
Jaroszewski et al General Thoracic SurgeryFigure 2. Percentage of thoracotomy patients
with no history of coronary artery disease,
with a history of CAD, and with symptomatic
CAD undergoing various cardiac testing mo-
dalities. Positive findings for ischemia of the
different testing modalities are depicted by
the black component of the bar representing
the modality. CAD, Coronary artery disease;
EST, exercise stress test; DSE, dobutamine
stress echocardiogram; Pthal, persantine thal-
lium stress test; Cath, cardiac catheterization.anatomy. Five additional angiograms were performed
because of a concerning history and ECG findings, and 2 of
those angiograms were significantly abnormal. Coronary
stenting was performed in 2 patients.
Myocardial Infarction
Postoperative MI occurred in 7 patients (2.4%) undergoing
a thoracotomy, 6 of whom had a history of CAD. Two ofThe Journal of Thothe patients who had a postoperative MI underwent revascu-
larization preoperatively with angioplasty and coronary
stenting. Table 2 summarizes the circumstances and details
of the adverse cardiac events. No significant difference was
found in the incidence of MI in patients with (n 5 184) or
without (n 5 110) detailed preoperative cardiac workup
(3.3% vs 0.9%, P 5 .29). Patients who underwent detailed
preoperative testing were older (mean age 64.06 10.3 yearsG
TSFigure 3. Percentage of lobectomy patients
with no history of coronary artery disease,
with a history of CAD, and with symptom-
atic CAD undergoing various cardiac test-
ing modalities. Positive findings for
ischemia of the different testing modalities
are depicted by the black component of the
bar representing the modality. CAD, Coro-
nary artery disease; EST, exercise stress
test; DSE, dobutamine stress echocardio-
gram; Pthal, persantine thallium stress
test; Cath, cardiac catheterization.racic and Cardiovascular Surgery c Volume 135, Number 3 651
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Age (y) Cardiac history Symptom profile Procedure
Preoperative
work up
65 CABG 5 y prior;
angio 1 y prior
DOE Left upper lobectomy ECG
TTE
Cath
51 None Asymptomatic Right upper lobectomy,
chest wall resection
ECG
TTE
61 LAD stent 3 y prior DOE Right lower and middle
lobectomy
ECG
TTE
DSE
Cath
72 Previous MI Stable angina Left upper lobectomy ECG
CABG 10 y prior TTE
DSE
Cath
59 History of CAD Asymptomatic Left pneumonectomy ECG
PThal
Right lower lobectomy
54 Prior MI Excellent exercise
tolerance
Right upper lobe
wedge
ECG
DSE
81 CABG 9 y prior DOE ECG
DSE
ASA, Aspirin; BB, beta-blocker; CABG, coronary artery bypass grafting; CAD, coronary artery disease; Cath, coronary angiogram; CHF, congestive heart
failure; DOE, dyspnea on exertion; DSE, dobutamine stress echocardiogram; ECG, electrocardiogram; EF, ejection fraction; LAD, left anterior descending;
MI, myocardial infarction; POD, postoperative day; PTCA, percutaneous transluminal coronary angioplasty; PThal, Persantine thallium stress test; RCA, right
coronary artery; TTE, transthoracic echocardiogram. *Aspirin and beta-blockers were started after MI.G
TSvs 58.46 11.7 years, P5 .0001) and had a higher prevalence
of a history of CAD (54% vs 7%, P 5 .001).
There were 4 (2.7%) post-lobectomy MIs. The details of
the patients affected are summarized in Table 2. The
incidence of MI was 2.8% in the patients who underwent
detailed cardiac testing (n 5 107) and 2.4% in those who
did not (n 5 42) (P 5 1.0). Again, patients who underwent
detailed cardiac testing tended to be older (mean age 66.4 6
9.4 years vs 62.56 11.7 years, P5 .04) and to have a higher
prevalence of a history of CAD (40% vs 12%, P 5 .003).
Mortality
There were 4 cardiac fatalities, 2 of whom had preoperative
coronary interventions (Table 2). One death was secondary
to acute occlusion of the left anterior descending (LAD) cor-
onary artery stent. This patient had a preoperative angiogram
that showed restenosis of the LAD stent and 100% right cor-
onary artery occlusion. Angioplasty of the LAD stent was652 The Journal of Thoracic and Cardiovascular Surgery c Maperformed, and perioperative beta-blockers and aspirin
were administered. On postoperative day 2, the patient was
reintubated for respiratory failure. On postoperative day 4,
sudden cardiac death occurred. An autopsy indicated
rethrombosis of the LAD stent.
The hospital stay was a median of 13 days (range 2–220
days). Two patients had extended hospital stays (158 and
220 days) because of multiple complications, including
sepsis and multisystem organ failure. The 30-day mortality
was 5.8% (17/294) with 7 deaths related to MI. Other causes
of death included hemorrhage (1), sepsis (5), pulmonary
embolism (2), multiorgan failure (1), acute respiratory dis-
tress syndrome (3), and tension pneumothorax (1).
Discussion
As the population of the United States continues to age, it is
estimated that by 2050 more than 19 million Americans will
be above 80 years old.6 Eighty percent of patients olderrch 2008
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Preoperative
interventions ASA/BB MI details
Anterolateral changes None 1/1 MI POD 2
EF 30%
Patent grafts
— None 2/2* Intraoperative MI
—
Lateral ischemia PTCA of LAD
in stent lesion
performed
34 d prior
1/1 MI POD 2, thrombosis
of LAD stent, deathEF 40%
Moderate-to-severe
anterior ischemia
80% mid-LAD lesion,
occluded RCA
Anterior changes RCA stent 1/1 MI POD 3 respiratory
failure, deathEF 50%
inferolateral ischemia
3-vessel CAD
PTCA distal
LAD 31 d prior
Lateral changes None 1/1 MI POD 3
Minimal inferoapical ischemia
Inferior infarct
Mild inferior ischemia
— None 11 MI POD 5, death
—
— None 1/1 MI POD 16, CHF,
ventricular
fibrillation, death
—
TABLE 2. ContinuedG
TSthan 80 years have identifiable CAD.7 Thoracic surgeons
will be faced with a growing number of elderly patients pre-
senting for surgery. With these statistics in mind, it is prob-
able that a majority of patients undergoing thoracotomy
procedures will have some degree of CAD. The risk of peri-
operative MI is estimated to be approximately 0.15% in pa-
tients without evidence of cardiac disease; however, in
patients with a history of MI, the incidence of reinfarction
during major noncardiac operations is estimated from
2.8% to 17.7%.8,9
Several indices have been successfully used to assess a pa-
tient’s cardiac risk.10–13 Simple and economic assessments,
such as taking a good history and reviewing the symptoms,
symptom-limited stair climbing, and resting ECG, can often
identify most patients with symptoms of unstable CAD, left
main CAD, critical aortic stenosis, or severe left ventricular
dysfunction.13–15 Until recently, those simple, yet time-
tested, clinical evaluations were marginalized in favor of
elaborate stress testing, such as DSE, Pthal, and EST. SuchThe Journal of Thornoninvasive evaluations were regarded as the gold standard
for cardiac risk stratification. Furthermore, if we move be-
yond the decision to submit a patient for a detailed ische-
mia-sensitive cardiac workup, the need for coronary
intervention to remedy the cardiac stigmata before noncar-
diac surgery remains controversial.
In our patient cohort there was no difference detected in
the incidence of postoperative MI in patients who underwent
a detailed preoperative cardiac testing that went beyond
a thorough clinical evaluation (history and physical examina-
tion with ECG) and those who did not. In the subset of pa-
tients with no cardiac disease elicited by careful clinical
evaluation, the results of the majority of the detailed cardiac
testing (DSE, Pthal, EST, or coronary angiogram) were unre-
markable or negative (Figures 2 and 3), and none required
a coronary intervention. Therefore, the yield of such testing
in this patient subset is low and not generally indicated. On
the other hand, in patients with cardiac disease determined
by careful clinical evaluation, further risk stratification byacic and Cardiovascular Surgery c Volume 135, Number 3 653
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findings for CAD and in some cases led to corrective revas-
cularization.
It is significant that 2 of the patients who had a post-tho-
racotomy MI underwent revascularization preoperatively
with angioplasty or coronary stenting. McFalls and col-
leagues5 recently evaluated the utility of preoperative cardiac
evaluation and intervention before elective major vascular
surgery in a Veterans Affairs cooperative study. Patients
with clinically significant but stable CAD were randomly
assigned to undergo preoperative coronary revascularization
(PTCA or CABG) versus optimized medical therapy
followed by the planned vascular operation. There were no
postoperative differences of in-hospital death or MI between
the 2 groups. These results indicate that coronary revascular-
ization does not provide an additional benefit in reducing the
incidence of perioperative cardiac death or MI provided
optimal medical management is instituted in patients under-
going vascular surgery.
In our series, the risk ofMI in all patients undergoing a pro-
cedure involving a thoracotomywas 2.4% and 2.7% if a lobec-
tomy was performed. This should be balanced against the risk
of coronary revascularization. Accepted operative mortality
associated with CABG is 1% to 2%, and percutaneous coro-
nary interventions have an age-dependent risk of MI, stroke,
and death ranging from 0.5% to 4%.16 Given that revasculari-
zation is not completely protective, the mortality risk of coro-
nary revascularizationmay compound the risk of thoracotomy.
A higher risk of coronary events andmortality in the setting of
noncardiac surgery shortly after coronary intervention has
been reported.17,18 The obligatory antiplatelet therapy require-
ments following today’s drug-eluting stents will significantly
delay the treatment of the underlying thoracic disease.
Currently, there is a trend that is leading away from rou-
tine detailed preoperative cardiac testing and invasive inter-
ventions and instead focusing on medical therapy,
including beta-blockers, to reduce the risk of perioperative
cardiac events, especially in those with known stable
CAD.3 The DECREASE trial showed a nearly 85% reduction
in the combined incidence of nonfatal MI and death from car-
diac causes after elective vascular surgery, owing to effective
preoperative, intraoperative, and postoperative beta-block-
age.19 The American College of Cardiology/American Heart
Association guidelines were recently updated to reflect the
growing body of evidence regarding the importance of peri-
operative beta-blockers in patients undergoing noncardiac
surgery.20 The modern era of intraoperative beta-blockade,
aspirin, and statin use has significantly affected the coronary
risks of surgical patients. In addition, there is some evidence
that postoperative epidural analgesia, especially thoracic
epidural analgesia, significantly reduces the rate of postoper-
ative MI.21
We believe that detailed cardiac testing is rarely indicated
in patients who according to a careful clinical assessment are654 The Journal of Thoracic and Cardiovascular Surgery c Madeemed to be at low cardiac risk for a thoracotomy. In the
presence of a history of CAD or significant risk factors, non-
invasive cardiac testing can help quantify the degree of sever-
ity of ischemia and determine the need for invasive coronary
angiography and intervention. Prophylactic revascularization
before thoracotomy has limited indications and is not fully
protective against postoperative adverse cardiac events. In-
deed, careful clinical risk assessment and optimal periopera-
tive medical management can avoid unnecessary treatment
delays by avoiding unnecessary cardiac testing in many
patients needing a thoracotomy.
There are several limitations relating to this study.
Given its retrospective nature, it is difficult to factor out
the individual biases in the decision to test for or treat
preexisting cardiac disease. Surgical judgment undoubtedly
influenced decision-making at different stages in the pa-
tient care plan, and surgeons with different levels of expe-
rience were involved in patient care during the study
period. In addition, although the subject of the study was
surgery involving a thoracotomy incision, there was a sig-
nificant degree of heterogeneity in the nature and extent of
the surgeries performed. However, similar results regarding
the role and impact of detailed cardiac testing were
encountered with a more focused analysis addressing the
lobectomy subset.
Conclusions
The decision to submit a patient undergoing a thoracotomy to
detailed preoperative cardiac testing for further risk
stratification should be selective and guided by a careful
clinical evaluation. However, such testing and subsequent
prethoracotomy corrective coronary intervention did not
show definite benefit in avoidingMI in the context of modern
era medical cardiac risk management.
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